JP2022535743A5 - - Google Patents
Info
- Publication number
- JP2022535743A5 JP2022535743A5 JP2021570361A JP2021570361A JP2022535743A5 JP 2022535743 A5 JP2022535743 A5 JP 2022535743A5 JP 2021570361 A JP2021570361 A JP 2021570361A JP 2021570361 A JP2021570361 A JP 2021570361A JP 2022535743 A5 JP2022535743 A5 JP 2022535743A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- independently selected
- group
- substituted
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962854288P | 2019-05-29 | 2019-05-29 | |
| US62/854,288 | 2019-05-29 | ||
| PCT/US2020/035249 WO2020243519A1 (en) | 2019-05-29 | 2020-05-29 | Compounds and compositions for treating conditions associated with sting activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022535743A JP2022535743A (ja) | 2022-08-10 |
| JP2022535743A5 true JP2022535743A5 (cg-RX-API-DMAC7.html) | 2023-06-01 |
Family
ID=71787083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021570361A Pending JP2022535743A (ja) | 2019-05-29 | 2020-05-29 | Sting活性に関連する状態を治療するための化合物および組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220227760A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3976584A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022535743A (cg-RX-API-DMAC7.html) |
| MA (1) | MA56047A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020243519A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI873098B (zh) | 2018-07-03 | 2025-02-21 | 瑞士商諾華製藥公司 | 用於治療與sting活性相關之病症的化合物及組合物 |
| US20230141284A1 (en) | 2020-04-10 | 2023-05-11 | Ono Pharmaceutical Co., Ltd. | Cancer therapeutic method |
| WO2022133046A2 (en) * | 2020-12-16 | 2022-06-23 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
| US20240051970A1 (en) * | 2020-12-16 | 2024-02-15 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
| JP2024504002A (ja) * | 2020-12-22 | 2024-01-30 | アイエフエム デュー インコーポレイテッド | がんを処置する方法 |
| JP2024500877A (ja) * | 2020-12-22 | 2024-01-10 | アイエフエム デュー インコーポレイテッド | がんを処置する方法 |
| US20240122903A1 (en) | 2020-12-22 | 2024-04-18 | Ifm Due Inc. | Methods of treating cancer |
| JP2024500874A (ja) | 2020-12-22 | 2024-01-10 | アイエフエム デュー インコーポレイテッド | がんを処置する方法 |
| JP2024502474A (ja) | 2021-01-08 | 2024-01-19 | アイエフエム デュー インコーポレイテッド | Sting活性に関連する状態を治療するための、尿素を有するヘテロ二環式化合物または類似体およびその組成物 |
| AU2022326463A1 (en) | 2021-08-10 | 2024-02-22 | Novartis Pharma Ag | Compounds and compositions for treating conditions associated with sting activity |
| WO2024064358A1 (en) | 2022-09-23 | 2024-03-28 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001290912A1 (en) * | 2000-09-15 | 2002-03-26 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| MY153898A (en) * | 2005-06-22 | 2015-04-15 | Plexxikon Inc | Compounds and methods for kinase modulation, and indications therefor |
| KR20130088002A (ko) * | 2010-01-13 | 2013-08-07 | 재단법인 한국파스퇴르연구소 | 항-감염성 피리도(1,2-a)피리미딘 |
| WO2012075380A1 (en) | 2010-12-03 | 2012-06-07 | The Trustees Of The University Of Pennsylvania | Tip60 inhibitors |
| JP6121658B2 (ja) * | 2011-06-29 | 2017-04-26 | 大塚製薬株式会社 | 治療用化合物、及び関連する使用の方法 |
| US9260426B2 (en) * | 2012-12-14 | 2016-02-16 | Arrien Pharmaceuticals Llc | Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors |
| CU24377B1 (es) | 2013-05-18 | 2018-12-05 | Aduro Biotech Inc | Dinucléotidos de purina cíclicos y composiciones de los mismos útiles para inducir la producción de interferón de tipo i dependientes de sting |
| AU2014340269B2 (en) | 2013-10-21 | 2018-06-21 | Drexel University | Use of STING agonists to treat chronic hepatitis B virus infection |
| US9580430B2 (en) * | 2014-02-28 | 2017-02-28 | The Regents Of The University Of Michigan | 9H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain inhibitors |
| EP3632915A1 (en) * | 2014-11-27 | 2020-04-08 | Genentech, Inc. | 4,5,6,7-tetrahydro-1 h-pyrazolo[4,3-c]pyridin-3-amine compounds as cbp and/or ep300 inhibitors |
| US12213978B2 (en) * | 2018-11-15 | 2025-02-04 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Madrasin-derivative compounds, composition and uses thereof for treating cancer |
| EP3883651A1 (en) * | 2018-11-19 | 2021-09-29 | IFM Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
-
2020
- 2020-05-29 US US17/610,570 patent/US20220227760A1/en not_active Abandoned
- 2020-05-29 MA MA056047A patent/MA56047A/fr unknown
- 2020-05-29 WO PCT/US2020/035249 patent/WO2020243519A1/en not_active Ceased
- 2020-05-29 EP EP20746384.5A patent/EP3976584A1/en not_active Withdrawn
- 2020-05-29 JP JP2021570361A patent/JP2022535743A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023509422A5 (cg-RX-API-DMAC7.html) | ||
| WO2023072197A1 (en) | Piperidinyl indole derivatives, preparation methods and medicinal uses thereof | |
| JP7128969B2 (ja) | Pcsk9阻害剤及びその使用方法 | |
| JP6353529B2 (ja) | 置換されたテトラヒドロカルバゾールおよびカルバゾールカルボキサミド化合物 | |
| JP4890723B2 (ja) | TNFαインヒビターとして有用なクマリン誘導体 | |
| AU2003258576B2 (en) | Pyrrolidinedione substituted piperidine-phthalazones as PDE4 inhibitors | |
| RU2737190C2 (ru) | Ингибиторы репликации вируса гриппа, способы их применения и использование | |
| US20080227789A1 (en) | Diaminothiazoles useful as axl inhibitors | |
| US6605624B1 (en) | Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity | |
| US20050267114A1 (en) | Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient | |
| RU2007119784A (ru) | Бициклические производные пиримидина, ингибирующие вич | |
| PE20011166A1 (es) | Piridinas, pirimidinas, purinonas, pirrolopirimidinonas y pirrolopiridinonas como antagonistas del factor liberador de corticotropina | |
| AR038864A1 (es) | Inhibidores pirimidina y piridina biciclicos de la p38 quinasa | |
| JP6353530B2 (ja) | キナーゼ阻害剤として有用なカルバゾールカルボキサミド化合物 | |
| CZ294603B6 (cs) | Deriváty karboxylové kyseliny | |
| AR045260A1 (es) | Compuestos que contienen imidazo-oxima sustituidos | |
| RU2008130884A (ru) | Гетероциклические ингибиторы янус-киназы 3 | |
| RU2008109185A (ru) | Получение и применение тетрагидропиролло[3, 2-с]пиридин-4-оновых производных для лечения ожирения, психиатрических и неврологических расстройств | |
| RU2003134371A (ru) | Пиразоло [1, 5-а] пиридины и содержащие их лекарственные средства | |
| AU2013277476A1 (en) | 1,2,4-triazine-6-carboxamide kinase inhibitors | |
| JP2024502473A5 (cg-RX-API-DMAC7.html) | ||
| JP2014528450A (ja) | 肝細胞癌を含む癌の阻害剤、および肝炎ウイルス複製の阻害剤としての置換アミノチアゾール | |
| RU2009128968A (ru) | Производные изосорбидмононитрата для лечения повышенной внутриглазной гипертензии | |
| AR055431A1 (es) | Derivados del acido 4-amino-tieno[3,2-c]piridina-7-carboxilico | |
| CN115873000B (zh) | 异喹啉酮类及喹唑啉酮类化合物及其组合物和用途 |